An estimate of the median costs of trials conducted in 2015-16 for the development of 10 cancer drugs was $648 billion.
Makadirio ya gharama ya wastani ya majaribio ya mwaka wa 2015 hadi 2016 ya kukuza dawa 10 za kuzuia saratani ilikuwa dola milioni 648.